Psychiatry Drug Alerts
Psychiatry Drug Alerts is an 8-page monthly update on the efficacy and safety of psychiatric drugs. The ALERTS in Psychiatry Drug Alerts are summaries, from a variety of journals, that can help you solve a problem, warn you about safety, or reassure you about efficacy. You can be assured that Psychiatry Drug Alerts is timely and thorough. We screen over 20,000 citations per week. You can also be assured of objectivity because Psychiatry Drug Alerts is independent. There is no sponsorship or advertisers of any kind associated with Psychiatry Drug Alerts. In fact we call special attention to manufacturer-sponsored studies.
You'll find well-written, easy to read updates from a diverse selection of journals. Here's a selection from recent issues. . .
| Managing NMS Current Treatment | Options in Neurology |
| Fish Oil Supplementation in Pregnancy | Archives of Disease in Childhood |
| Sibutramine for Clozapine Weight Gain | Acta Psychiatrica Scandinavica |
| SSRIs and Fracture Risk | Archives of Internal Medicine |
| Lamotrigine in Older Patients | Int’l J of Geriatric Psychiatry |
| Moclobemide SSRI Comparison | Canadian J of Psychiatry |
| Ramelteon in Sleep Apnea | Sleep and Breathing |